Stock 002424 GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Guizhou Bailing Group Pharmaceutical Co., Ltd.

Equities

002424

CNE100000PY3

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
6.46 CNY +1.25% Intraday chart for Guizhou Bailing Group Pharmaceutical Co., Ltd. +1.57% -20.35%
10:36am Large-Scale Equipment Renewals Seen to Raise Demand for Chinese High-End Steel Products, Trade Body Says MT
May. 02 China to Tweak Production Limits for Steel as Industry Faces Low Prices, Oversupply MT

Valuation

Fiscal Period: December 2022 2023 2024 2025
Capitalization 1 11,404 11,236 8,950 -
Enterprise Value (EV) 1 11,404 11,236 8,950 8,950
P/E ratio 81.6 x -27 x 19.6 x 13.2 x
Yield - - - -
Capitalization / Revenue - 2.64 x 1.65 x 1.38 x
EV / Revenue - 2.64 x 1.65 x 1.38 x
EV / EBITDA - -30.2 x 10.5 x 8.13 x
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 3.26 x 1.61 x 1.44 x
Nbr of stocks (in thousands) 1,397,598 1,385,502 1,385,502 -
Reference price 2 8.160 8.110 6.460 6.460
Announcement Date 4/28/23 4/30/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025
Net sales 1 - 4,263 5,434 6,475
EBITDA 1 - -372 855 1,100
EBIT 1 - -484.4 560 827.8
Operating Margin - -11.36% 10.31% 12.78%
Earnings before Tax (EBT) 1 - -493.1 548.1 823
Net income 1 138.2 -414.5 460.3 691.6
Net margin - -9.72% 8.47% 10.68%
EPS 2 0.1000 -0.3000 0.3300 0.4900
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 4/28/23 4/30/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - -11.2% 8.13% 10.9%
ROA (Net income/ Total Assets) - - - -
Assets 1 - - - -
Book Value Per Share 2 - 2.490 4.010 4.500
Cash Flow per Share 2 - 0.0900 -0.5300 1.390
Capex - - - -
Capex / Sales - - - -
Announcement Date 4/28/23 4/30/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Guizhou Bailing Group Pharmaceutical Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.46
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Alternative Medicine

1st Jan change Capi.
GUIZHOU BAILING GROUP PHARMACEUTICAL CO., LTD. Stock Guizhou Bailing Group Pharmaceutical Co., Ltd.
-20.35% 1.24B
DONG-E-E-JIAO CO.,LTD. Stock Dong-E-E-Jiao Co.,Ltd.
+39.33% 6.11B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD. Stock Shijiazhuang Yiling Pharmaceutical Co., Ltd.
-18.38% 4.35B
TASLY PHARMACEUTICAL GROUP CO., LTD Stock Tasly Pharmaceutical Group Co., Ltd
-9.17% 3.18B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED Stock Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited
+3.98% 3.15B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD. Stock Shandong Buchang Pharmaceuticals Co., Ltd.
-3.41% 2.51B
HENAN LINGRUI PHARMACEUTICAL CO., LTD. Stock Henan Lingrui Pharmaceutical Co., Ltd.
+48.74% 1.98B
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. Stock GuangYuYuan Chinese Herbal Medicine Co., Ltd.
-4.82% 1.74B
TIBET CHEEZHENG TIBETAN MEDICINE CO., LTD. Stock Tibet Cheezheng Tibetan Medicine Co., Ltd.
-1.24% 1.63B
TIANJIN CHASE SUN PHARMACEUTICAL CO.,LTD Stock Tianjin Chase Sun Pharmaceutical Co.,Ltd
-8.96% 1.6B
Alternative Medicine
  1. Stock Market
  2. Equities
  3. 002424 Stock
  4. Financials Guizhou Bailing Group Pharmaceutical Co., Ltd.